Market Cap (In KRW)
369.92 Billion
Revenue (In KRW)
3.41 Billion
Net Income (In KRW)
-8.75 Billion
Avg. Volume
139.33 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 12010.0-27950.0
- PE
- -
- EPS
- -
- Beta Value
- -0.087
- ISIN
- KR7228760005
- CUSIP
- -
- CIK
- -
- Shares
- 23990079.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Sung-Whan An
- Employee Count
- -
- Website
- https://www.genomictree.com
- Ipo Date
- 2017-04-05
- Details
- Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraTect-KRAS and AccuraTect-BRAF that are companion diagnostics for colorectal cancer; AccuraTect-EGFR, a companion diagnostic for lung cancer; and AccuraDTect SARS-CoV-2 RT-qPCR kits, as well as test providers. Genomictree Inc. was founded in 2000 and is headquartered in Daejeon, South Korea.
More Stocks
-
GWM
-
KHC
-
6199SERAKU Co., Ltd.
6199
-
BZ7A
-
VINTAGESVintage Securities Limited
VINTAGES
-
MFIN
-
FBSGFFabled Silver Gold Corp.
FBSGF
-
WVE